our research
Pelican is dedicated to improving quality of life and survival for patients with cancers of the pelvic region and liver. If you wish to apply for a Pelican research grant please see all the information provided for researchers. Please carefully read the Guidance as well as the Terms and Conditions before sending applications.
Pelican is interested in hearing proposals covering our area of interest: improvements to precision surgery for rectal, liver or prostate cancer. Once an application has been received it will be reviewed by external peer review and the Pelican Research Review Panel. Applicants will be kept informed about progress of their application.
Pelican Research
Research is an essential element of our model for improvement for cancer surgery. Our research to-date is published in the relevant sections bowel, liver, prostate, bladder, kidney, radiology and pathology.
Research programmes that we are currently supporting include:
MERCURY RESEARCH PROGRAMME:
- Follow up of patients in the MERCURY Study (Phase 1)
- Low Rectal Cancer Study (Launched January 2007)
- TME Intervention Audit (National MDT-TME Programme)
- MRI Impact Study (National MDT-TME Programme)
- EXPERT C (Collaborative programme with Royal Marsden)
- Complete Response Study (Collaborative pilot study with Royal Marsden)
Liver Quality of Life Study
Prostate HIFU Focal Therapy Study (Collaborative project with University College Hospital in London)
Prostate MRI Spectroscopy Study (Joint project with Royal Marsden)
Basingstoke Urology Research (launched January 2007)
